HPV vaccinations for U.S. teens rise slightly: CDC

The percentage of U.S. teenagers vaccinated against the human papillomavirus increased slightly in 2014, but the rate lags behind other immunizations, the Centers for Disease Control and Prevention said on Thursday. The HPV vaccine, sold as Gardasil by Merck & Co and Cervarix by GlaxoSmithKline, protects against the most common sexually transmitted infection. The CDC said the percentage of girls between 13 and 17 years old who received at least one dose of the vaccine increased by 3.3 percentage points to 60 percent.
Sexual Health News Headlines – Yahoo! News